Why the study?
Does erenumab increase the risk of elevated blood pressure in treated patients?
Does erenumab increase the risk of elevated blood pressure in treated patients?
Erenumab use is associated with a new safety risk of elevated blood pressure, prompting a label update to include hypertension in the Warnings and Precautions section.
Answers are grounded in this paper and cite their sources.
May warrant BP monitoring with erenumab; leaves open the need for confirmatory prospective data.
This case series suggest an association between elevated BP and use of erenumab. In light of our findings, the erenumab (Aimovig) prescribing information was amended to include hypertension in the Warnings and Precautions section.
No takes yet. Share an insight, caveat, or question.
Saely et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: